A randomized, double-blind, placebo-controlled

Project: Research project

Project Details

Description

A randomized, double-blind, placebo-controlled, multicenter, phase 3 efficacy and safety study of subcutaneous anakinra (Kineret) in patients with Still's disease (SJIA and AOSD) followed by an open-label extension
StatusActive
Effective start/end date1/1/171/1/21

Funding

  • SWEDISH ORPHAN BIOVITRUM AB

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.